ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,253, issued on Sept. 2.
"2,4,6-trisubstituted 1,3,5-triazines as modulators of CX3CR1" was invented by Karolina Nilsson (Sodertalje, Sweden), Martin Bauer (Sodertalje, Sweden), Maria Olwegard Halvarsson (Sodertalje, Sweden), Mikael Brink (Sodertalje, Sweden) and Fredrik Bergstrom (Sodertalje, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There are disclosed certain 2,4,6-trisubstituted 1,3,5-triazine compounds of Formula (I),and pharmaceutically acceptable salts thereof, together with compositions containing them and their use in therapy. The compounds are modulators of CX3CR1 and are thereby particularly useful in the treatment or prophylax...